Fumouze

 

In 1975, Laboratoires Fumouze developed and brought to market STÉRIMAR™, the first application of sea water solution in physiological concentration to nasal hygiene. For more than 30 years, STÉRIMAR™ has always set out to offer the most effective products. Since 2001, Laboratoires Fumouze has represented the pharmaceutical activity of SOFIBEL, a French subsidiary of Church & Dwight (New York, USA).

Precursor on the French market, STÉRIMAR™ has always been the leading nasal hygiene spray best known to health care professionals and consumers alike. Laboratoires FUMOUZE are set up in more than 80 countries worldwide.